On Jul 6, 2021, Standigm closed a Series C round and raised $10,000,000 from lead investor Pavilion Capital.

About the company: Standigm is located in Seoul, South Korea, Asia. “Standigm discovers drugs using AI, saving time and cost when compared to traditional methods. Our AI reveals the patterns hiding in the today’s biomedical data that will lead to tomorrow’s medicines.” The company has proprietary AI platforms encompassing novel target identification to lead generation to generate commercially valuable drug pipelines.

Company website: www.standigm.com